BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1960360)

  • 1. The utilization of fecal occult blood testing in the institutionalized elderly.
    Klos SE; Drinka P; Goodwin JS
    J Am Geriatr Soc; 1991 Dec; 39(12):1169-73. PubMed ID: 1960360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
    Scales CD; Fein S; Muir AJ; Rockey DC
    J Clin Gastroenterol; 2006; 40(10):913-8. PubMed ID: 17063111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fecal occult blood on obscure gastrointestinal bleeding: observational study.
    Kobayashi Y; Watabe H; Yamada A; Suzuki H; Hirata Y; Yamaji Y; Yoshida H; Koike K
    World J Gastroenterol; 2015 Jan; 21(1):326-32. PubMed ID: 25574108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid fecal cytokeratin-19 test and fecal occult blood test in screening for gastrointestinal diseases.
    Kim H; Kim Y; Yoon S; Lim J; Kim M; Lee S; Kang S; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2006; 36(3):294-8. PubMed ID: 16951270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.
    Narula N; Ulic D; Al-Dabbagh R; Ibrahim A; Mansour M; Balion C; Marshall JK
    Can J Gastroenterol Hepatol; 2014 Sep; 28(8):421-6. PubMed ID: 25014182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An audit of the utility of in-patient fecal occult blood testing.
    Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
    Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
    Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
    Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes.
    Mosadeghi S; Ren H; Catungal J; Yen I; Liu B; Wong RJ; Bhuket T
    J Postgrad Med; 2016; 62(2):91-5. PubMed ID: 27089107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of occult gastrointestinal lesions by stool guaiac testing in a geriatric hospital.
    Mangla JC; Pereira M; Murphy J
    J Am Geriatr Soc; 1981 Oct; 29(10):473-5. PubMed ID: 7276414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal occult blood testing in hospitalized patients.
    Pochapin MB; Fine SN; Eisorfer RM; Rigas B
    J Clin Gastroenterol; 1994 Dec; 19(4):274-7. PubMed ID: 7876504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An occult finding in heparin drip order set.
    Ponor L; Khaliq W; Hanumanthu R; Kim D; Wright S
    Hosp Pract (1995); 2015; 43(4):212-6. PubMed ID: 26391333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate use of the faecal occult blood test in a university hospital in the Netherlands.
    van Rijn AF; Stroobants AK; Deutekom M; Lauppe C; Sturk A; Bossuyt PM; Fockens P; Dekker E
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1266-9. PubMed ID: 23022920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic testing following fecal occult blood screening in the elderly.
    Lurie JD; Welch HG
    J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital fecal occult blood testing in the ambulatory urology clinic.
    Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
    J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
    van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
    Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.